Catalysts for $AVBP
15 tracked
Aug 14, 2026
earnings
ArriVent BioPharma, Inc. earnings
ArriVent BioPharma, Inc.
→
May 15, 2026
earnings
ArriVent BioPharma, Inc. earnings
ArriVent BioPharma, Inc.
→
May 11, 2026
earnings
ArriVent BioPharma, Inc. earnings
ArriVent BioPharma, Inc.
→
Feb 24, 2026
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Feb 24, 2026
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Mar 12, 2025
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Dec 20, 2024
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Sep 12, 2024
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Oct 13, 2023
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Oct 11, 2023
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Feb 11, 2022
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Apr 8, 2020
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
May 24, 2019
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Jan 23, 2019
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→
Jun 27, 2018
approval
BRAFTOVI (ENCORAFENIB) — FDA approval
encorafenib
→